Andreas Liebl

1.7k total citations
65 papers, 1.3k citations indexed

About

Andreas Liebl is a scholar working on Endocrinology, Diabetes and Metabolism, Speech and Hearing and Social Psychology. According to data from OpenAlex, Andreas Liebl has authored 65 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Speech and Hearing and 16 papers in Social Psychology. Recurrent topics in Andreas Liebl's work include Diabetes Management and Research (35 papers), Diabetes Treatment and Management (25 papers) and Noise Effects and Management (22 papers). Andreas Liebl is often cited by papers focused on Diabetes Management and Research (35 papers), Diabetes Treatment and Management (25 papers) and Noise Effects and Management (22 papers). Andreas Liebl collaborates with scholars based in Germany, United States and Denmark. Andreas Liebl's co-authors include Sabine J. Schlittmeier, Robert J. Ligthelm, Philip Leistner, Jens Sandahl Christiansen, Jürgen Hellbrück, Marcel Kaiser, Jaime A. Davidson, Alan J. Garber, Rudolf Prager and Richard M. Bergenstal and has published in prestigious journals such as Diabetes Care, The Journal of the Acoustical Society of America and Diabetes Obesity and Metabolism.

In The Last Decade

Andreas Liebl

62 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Liebl Germany 22 784 354 298 251 215 65 1.3k
Joaquín Téran‐Santos Spain 22 21 0.0× 105 0.3× 135 0.5× 46 0.2× 356 1.7× 39 2.5k
Boris Gojanovic Switzerland 14 29 0.0× 27 0.1× 415 1.4× 11 0.0× 8 0.0× 64 1.2k
Hui Zhu China 13 8 0.0× 37 0.1× 34 0.1× 55 0.2× 16 0.1× 44 519
F. Horák Austria 15 44 0.1× 111 0.3× 98 0.3× 5 0.0× 110 0.5× 36 1.5k
David W. Collins United States 12 14 0.0× 12 0.0× 191 0.6× 21 0.1× 150 0.7× 27 988
José Antonio Rodríguez Marroyo Spain 25 23 0.0× 6 0.0× 39 0.1× 70 0.3× 23 0.1× 105 1.8k
Hyoki Lee South Korea 16 16 0.0× 39 0.1× 56 0.2× 4 0.0× 43 0.2× 46 736
Hamid Bateni United States 11 86 0.1× 10 0.0× 104 0.3× 9 0.0× 98 0.5× 23 1.1k
Miroslav Janura Czechia 17 96 0.1× 13 0.0× 120 0.4× 33 0.1× 45 0.2× 121 925
Neil Maxwell United Kingdom 28 20 0.0× 13 0.0× 15 0.1× 397 1.6× 12 0.1× 93 2.3k

Countries citing papers authored by Andreas Liebl

Since Specialization
Citations

This map shows the geographic impact of Andreas Liebl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Liebl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Liebl more than expected).

Fields of papers citing papers by Andreas Liebl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Liebl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Liebl. The network helps show where Andreas Liebl may publish in the future.

Co-authorship network of co-authors of Andreas Liebl

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Liebl. A scholar is included among the top collaborators of Andreas Liebl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Liebl. Andreas Liebl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liebl, Andreas, et al.. (2019). New Design of a Percutaneous Port System for Continuous Intraperitoneal Insulin Infusion. Journal of Diabetes Science and Technology. 13(6). 1158–1160. 6 indexed citations
2.
Liebl, Andreas. (2016). Management of postprandial glucose: Recommended targets and treatment with biphasic insulin. Primary care diabetes. 10(6). 391–397. 3 indexed citations
3.
Schlittmeier, Sabine J., et al.. (2015). The impact of road traffic noise on cognitive performance in attention-based tasks depends on noise level even within moderate-level ranges. Noise and Health. 17(76). 148–148. 40 indexed citations
4.
Liebl, Andreas, et al.. (2013). Continuous Glucose Monitoring: Evidence and Consensus Statement for Clinical Use. Journal of Diabetes Science and Technology. 7(2). 500–519. 49 indexed citations
5.
6.
Meneghini, Luigi, Andreas Liebl, & Martin J. Abrahamson. (2010). Insulin detemir: A historical perspective on a modern basal insulin analogue. Primary care diabetes. 4. S31–S42. 17 indexed citations
7.
Cucinotta, Domenico, Olga Mikhailovna Smirnova, J. S. Christiansen, et al.. (2009). Three different premixed combinations of biphasic insulin aspart – comparison of the efficacy and safety in a randomized controlled clinical trial in subjects with type 2 diabetes. Diabetes Obesity and Metabolism. 11(7). 700–708. 20 indexed citations
8.
Liebl, Andreas. (2009). Insulin intensification â the rationale and the target. International Journal of Clinical Practice. 63(164). 1–5. 8 indexed citations
9.
Liebl, Andreas, Roel P.L.M. Hoogma, Éric Renard, et al.. (2009). A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion. Diabetes Obesity and Metabolism. 11(11). 1001–1008. 53 indexed citations
10.
Christiansen, Jens Sandahl, Andreas Liebl, Jaime A. Davidson, Robert J. Ligthelm, & S. Halimi. (2009). Mid‐ and high‐ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control. Diabetes Obesity and Metabolism. 12(2). 105–114. 10 indexed citations
11.
Davidson, Jaime A., Andreas Liebl, Jens Sandahl Christiansen, et al.. (2009). Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: A meta-analysis. Clinical Therapeutics. 31(8). 1641–1651. 52 indexed citations
12.
Liebl, Andreas. (2008). Myths, Realities and Practicalities in the Initiation and Intensification of Insulin Therapy in Type 2 Diabetes. touchREVIEWS in Endocrinology. 4(2). 27–27. 2 indexed citations
13.
Liebl, Andreas, Rudolf Prager, Katharina Binz, et al.. (2008). Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial. Diabetes Obesity and Metabolism. 11(1). 45–52. 125 indexed citations
14.
Hellbrück, Jürgen & Andreas Liebl. (2008). Noise effects on cognitive performance. Cardiology Journal. 31(1). 133–146. 3 indexed citations
15.
Schlittmeier, Sabine J., et al.. (2007). BACKGROUND SPEECH VARYING IN INTELLIGIBILITY - EFFECTS ON COGNITIVE PERFORMANCE AND PERCEIVED DISTURBANCE. Publication Server of the Catholic University Eichstätt-Ingolstadt (Catholic University of Eichstätt-Ingolstadt). 38. 1 indexed citations
16.
Hammond, Peter, Andreas Liebl, & Stefan Gründer. (2007). International survey of insulin pump users: Impact of continuous subcutaneous insulin infusion therapy on glucose control and quality of life. Primary care diabetes. 1(3). 143–146. 27 indexed citations
17.
Liebl, Andreas. (2006). The when and how of insulin initiation in type 2 diabetes. Current Medical Research and Opinion. 23(1). 129–132. 1 indexed citations
18.
Ligthelm, Robert J., Ulrik Mouritzen, Helle Lynggaard, et al.. (2006). Biphasic Insulin Aspart Given Thrice Daily is as Efficacious as a Basal-Bolus Insulin Regimen with Four Daily Injections. Experimental and Clinical Endocrinology & Diabetes. 114(9). 511–519. 50 indexed citations
19.
Halimi, Serge, Philip Raskin, Andreas Liebl, et al.. (2005). Efficacy of biphasic insulin aspart in patients with type 2 diabetes. Clinical Therapeutics. 27. S57–S74. 31 indexed citations
20.
Liebl, Andreas. (2002). Challenges in optimal metabolic control of diabetes. Diabetes/Metabolism Research and Reviews. 18(S3). S36–S41. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joaquín Téran‐Santos Breakdown of academic impact, for papers by Boris Gojanovic Breakdown of academic impact, for papers by Hui Zhu Breakdown of academic impact, for papers by F. Horák Breakdown of academic impact, for papers by David W. Collins Breakdown of academic impact, for papers by José Antonio Rodríguez Marroyo Breakdown of academic impact, for papers by Hyoki Lee Breakdown of academic impact, for papers by Hamid Bateni Breakdown of academic impact, for papers by Miroslav Janura Breakdown of academic impact, for papers by Neil Maxwell
Rankless by CCL
2026